Post written by Kais Zakharia, MD, from the Division of Gastroenterology, University of Massachusetts Chan Medical School–Baystate Medical Center, Springfield, Massachusetts, USA. Barrett’s esophagus (BE) remains the only known precursor to esophageal adenocarcinoma and, although the risk of progression varies with segment length and degree of dysplasia, endoscopic management has increasingly replaced surgery in well-selected patients. In …
Tag: Barret’s esophagus
Location and appearance of dysplastic Barrett’s esophagus recurrence after endoscopic eradication therapy: no additional yield from random biopsy sampling neosquamous mucosa
Post written by Tony He, MBBS, FRACP, and Andrew C.F. Taylor, MD, FRACP, from the Department of Gastroenterology, St Vincent’s Hospital, and the University of Melbourne, Melbourne, Victoria, Australia. We aimed to help inform surveillance guidelines in patients who had successful complete eradication of dysplastic Barrett’s esophagus (BE) by identifying the anatomic location, appearance, and histology …
Editor’s Choice- John Vargo
Associate Editor, John Vargo, MD, MPH, recommends the article "Liquid nitrogen spray cryotherapy in Barrett's esophagus with high-grade dysplasia: long-term results" by Sonia Gosain, MD, Kim Mercer, RN, William S. Twaddell, MD, Lance Uradomo, MD, MPH, Bruce D. Greenwald, MD from the August issue. This article gives us a clearer glimpse as to the safety and efficacy of cryotherapy in …
endoscopedia.com 